Polku Therapeutics
Pre-clinicalFirst-in-class disease-modifying therapies for neurodegeneration.
Founded
2018
Focus
Small Molecules
About
First-in-class disease-modifying therapies for neurodegeneration.
Funding History
1Total raised: $3.5M
Seed$3.5MVoima VenturesJun 15, 2022
Company Info
TypePrivate
Founded2018
LocationTurku, Finland
StagePre-clinical
Contact
SIMILAR COMPANIES
3PBIOVIAN
Pre-clinical · Turku
Faron Pharmaceuticals
Phase 1/2 · Turku
Finvector Vision Therapies
Pre-clinical · Kuopio
Bone Index
Pre-clinical · Kuopio
Genomill Health
Pre-clinical · Helsinki
Is this your company?
Claim your profile to update information, add pipeline data, and connect with investors.
Claim profile